In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models

Japanese Journal of Pharmacology

Volumn 87, Issue 1, 2001, Pages 21-26

  Takahara, A ^a   Hirasawa, A ^a   Dohmoto, H ^a   Shoji, M ^a   Yoshimoto, R ^a   Sugiyama, A ^a   Hashimoto, K ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

AP 792; Ventricular arrhythmia

Indexed keywords

4 (5H DIBENZO[A,D]CYCLOHEPT 5 YLIDENE) 1 [3 (3 METHOXY 2 NITROPHENYL) 2 PROPENYL]PIPERIDINE; 4 (5H DIBENZO[A,D]CYCLOHEPTEN 5 YLIDENE) 1 (4 CYCLOHEXYLBUTYL)PIPERIDINE; ADRENALIN; ANTIARRHYTHMIC AGENT; AP 792; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOSELECTIVITY; CORONARY ARTERY LIGATION; DOG; DRUG EFFECT; FEMALE; HEART VENTRICLE ARRHYTHMIA; IN VIVO STUDY; MALE; NONHUMAN;

EID: 0034791147     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.87.21     Document Type: Article

References (17)

1. Cyproheptadine in ventricular arrhythmias
2. Effects of serotonin antagonists on digitalis-induced ventricular arrthythmias
3. Antiarrhythmic activity of amitriptyline analogues in conscious dogs after myocardial infarction: Cyproheptadinium methiodide
4. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: Which electrophysiological characteristics of drugs are related to their effectiveness?
5. Effective plasma concentrations of antiarrhythmic drugs against sustained halothaneadrenaline arrhythmia in dogs
6. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: A comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165
7. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia
8. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models
9. 2+ channel blocker, in models of ventricular arrhythmia in dogs
10. 2+ channel blocker, AH-1058, assessed in canine arrhythmia models
11. Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia
12. The PACK trial: Morbidity and mortality effects of ketanserin. Prevention of atherosclerotic complications
13. Effective plasma concentrations of aprindine in canine ventricular arrhythmias
14. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias
15. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias
16. Antiarrhythmic effects of the class Ic antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models
17. Effects of AH-1058, a potent antiarrhythmic compound, on the membrane currents of guinea-pig cardiomyocytes